These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36633254)

  • 41. Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
    Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.
    Kim S; Lee D; Song JC; Cho SJ; Yun SM; Koh YH; Song J; Johnson GV; Jo C
    Biochem Biophys Res Commun; 2014 Nov; 454(1):196-201. PubMed ID: 25450380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
    Aragão Gomes L; Uytterhoeven V; Lopez-Sanmartin D; Tomé SO; Tousseyn T; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Verstreken P; Thal DR
    Acta Neuropathol; 2021 Feb; 141(2):173-192. PubMed ID: 33427938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Site-specific phosphorylation of tau impacts mitochondrial function and response to stressors.
    Isei MO; Girardi PA; Rodwell-Bullock J; Nehrke K; Johnson GVW
    J Neurochem; 2024 Jun; 168(6):1019-1029. PubMed ID: 37787052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates.
    Gyparaki MT; Arab A; Sorokina EM; Santiago-Ruiz AN; Bohrer CH; Xiao J; Lakadamyali M
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
    Suárez-Calvet M; Karikari TK; Ashton NJ; Lantero Rodríguez J; Milà-Alomà M; Gispert JD; Salvadó G; Minguillon C; Fauria K; Shekari M; Grau-Rivera O; Arenaza-Urquijo EM; Sala-Vila A; Sánchez-Benavides G; González-de-Echávarri JM; Kollmorgen G; Stoops E; Vanmechelen E; Zetterberg H; Blennow K; Molinuevo JL;
    EMBO Mol Med; 2020 Dec; 12(12):e12921. PubMed ID: 33169916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification.
    Barthélemy NR; Bateman RJ; Hirtz C; Marin P; Becher F; Sato C; Gabelle A; Lehmann S
    Alzheimers Res Ther; 2020 Mar; 12(1):26. PubMed ID: 32183883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Pluta R; Czuczwar SJ
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
    Aulston B; Liu Q; Mante M; Florio J; Rissman RA; Yuan SH
    J Alzheimers Dis; 2019; 72(2):575-585. PubMed ID: 31594233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
    J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.
    Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies.
    Fujiwara H; Watanabe S; Iwata M; Ueda S; Nobuhara M; Wada-Kakuda S; Misonou H; Miyasaka T
    Biochem Biophys Res Commun; 2020 Jan; 521(3):779-785. PubMed ID: 31699369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
    Trojanowski JQ; Lee VM
    FASEB J; 1995 Dec; 9(15):1570-6. PubMed ID: 8529836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.
    Miller EC; Teravskis PJ; Dummer BW; Zhao X; Huganir RL; Liao D
    Eur J Neurosci; 2014 Apr; 39(7):1214-24. PubMed ID: 24713000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
    Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
    J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.
    Sen T; Saha P; Jiang T; Sen N
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4418-4427. PubMed ID: 32051249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.